부산대학교 도서관

During the COVID-19 pandemic in Taiwan, the prevalence rate (annual rate of increase) of some drug-resistant bacteria tripled. The COVID-19 pandemic has once again highlighted the important role and importance of infectious disease specialists on the frontline of the fight against the pandemic. However, the national policy for the development of infectious disease medicine and personnel training is relatively poor, which has resulted in an increasing number of infectious disease specialists applying for examinations year after year. The continual shortage of infectious disease specialists may have led to an increase in antibiotic resistance. The 2022 report of the Taiwan Hospital Infection Control and Drug Resistance Surveillance Management System showed that drug resistance has increased significantly in regional hospitals compared to medical centers. There is no additional capacity for antimicrobial stewardship or other related infectious disease programs. The Infectious Diseases Society of Taiwan and the Infection Control Society of Taiwan hope that by introducing case management scales and strengthening the application of antibiotic management strategies, the cross-team integration of innovative and highly regulated drug use will be improved and the organizational structure of antibiotic management will be systematically constructed. Immediate treatment and strengthening of drug diversification strategies are required to reduce antibiotic resistance. In the post-pandemic era, incorporating antimicrobial drug use and antimicrobial resistance care scales into health insurance payment items is expected to reduce medical resource expenditure and achieve economic benefits. This should be deployed as early as possible to cope with the future antimicrobial drug resistance crisis.